Menu
Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,702 | Dovepress* | 8,198+ | 1,555 | 9,753 | |
| PubMed Central* | 504 | 178 | 682 | ||
| Totals | 8,702 | 1,733 | 10,435 | ||
|
*Since 10 April 2015 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar